IRIS Accounts Production v25.1.4.42 04857038 Board of Directors 1.2.24 31.1.25 31.1.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh048570382024-01-31048570382025-01-31048570382024-02-012025-01-31048570382023-01-31048570382023-02-012024-01-31048570382024-01-3104857038ns15:EnglandWales2024-02-012025-01-3104857038ns14:PoundSterling2024-02-012025-01-3104857038ns10:Director12024-02-012025-01-3104857038ns10:PrivateLimitedCompanyLtd2024-02-012025-01-3104857038ns10:SmallEntities2024-02-012025-01-3104857038ns10:AuditExempt-NoAccountantsReport2024-02-012025-01-3104857038ns10:SmallCompaniesRegimeForDirectorsReport2024-02-012025-01-3104857038ns10:SmallCompaniesRegimeForAccounts2024-02-012025-01-3104857038ns10:FullAccounts2024-02-012025-01-3104857038ns10:EntityNoLongerTradingButTradedInPast2024-02-012025-01-3104857038ns10:Director22024-02-012025-01-3104857038ns10:RegisteredOffice2024-02-012025-01-3104857038ns5:CurrentFinancialInstruments2025-01-3104857038ns5:CurrentFinancialInstruments2024-01-3104857038ns5:ShareCapital2025-01-3104857038ns5:ShareCapital2024-01-3104857038ns5:CapitalRedemptionReserve2025-01-3104857038ns5:CapitalRedemptionReserve2024-01-3104857038ns5:RetainedEarningsAccumulatedLosses2025-01-3104857038ns5:RetainedEarningsAccumulatedLosses2024-01-3104857038ns5:WithinOneYearns5:CurrentFinancialInstruments2025-01-3104857038ns5:WithinOneYearns5:CurrentFinancialInstruments2024-01-3104857038ns5:RetainedEarningsAccumulatedLosses2024-01-3104857038ns5:CapitalRedemptionReserve2024-01-3104857038ns5:RetainedEarningsAccumulatedLosses2024-02-012025-01-31
REGISTERED NUMBER: 04857038 (England and Wales)
















Unaudited Financial Statements for the Year Ended 31 January 2025

for

Prn Medical Transcription Limited

Prn Medical Transcription Limited (Registered number: 04857038)






Contents of the Financial Statements
for the Year Ended 31 January 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Prn Medical Transcription Limited

Company Information
for the Year Ended 31 January 2025







DIRECTORS: D J Bijl
Mrs I P M Bijl





REGISTERED OFFICE: 4 Highfield Road
Malvern
England
Worcestershire
WR14 1HS





REGISTERED NUMBER: 04857038 (England and Wales)





ACCOUNTANTS: Boyds Accountants
Britannia Court
5 Moor Street
Worcester
Worcestershire
WR1 3DB

Prn Medical Transcription Limited (Registered number: 04857038)

Balance Sheet
31 January 2025

31.1.25 31.1.24
Notes £    £   
CURRENT ASSETS
Debtors 4 4,109 4,430
Cash at bank 332,210 370,120
336,319 374,550
CREDITORS
Amounts falling due within one year 5 45,730 44,739
NET CURRENT ASSETS 290,589 329,811
TOTAL ASSETS LESS CURRENT
LIABILITIES

290,589

329,811

CAPITAL AND RESERVES
Called up share capital 300 300
Capital redemption reserve 6 600 600
Retained earnings 6 289,689 328,911
SHAREHOLDERS' FUNDS 290,589 329,811

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 29 July 2025 and were signed on its behalf by:





D J Bijl - Director


Prn Medical Transcription Limited (Registered number: 04857038)

Notes to the Financial Statements
for the Year Ended 31 January 2025

1. STATUTORY INFORMATION

Prn Medical Transcription Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Research and development
Expenditure on research and development is written off in the year in which it is incurred.


3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.25 31.1.24
£    £   
Directors' current accounts - 321
Tax 4,109 4,109
4,109 4,430

Prn Medical Transcription Limited (Registered number: 04857038)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2025

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.25 31.1.24
£    £   
Social security and other taxes 20 20
VAT 13,415 13,415
Other creditors 30,365 30,365
Directors' current accounts 199 -
Accrued expenses 1,731 939
45,730 44,739

6. RESERVES
Capital
Retained redemption
earnings reserve Totals
£    £    £   

At 1 February 2024 328,911 600 329,511
Profit for the year 10,278 10,278
Dividends (49,500 ) (49,500 )
At 31 January 2025 289,689 600 290,289

7. ULTIMATE CONTROLLING PARTY

The controlling party is D J Bijl.